Similarly, the use of NGS to identify a PIK3CA missense mutation in a patient without a definitive pathological diagnosis of cutaneous malignancy has allowed targeted treatment of an otherwise complex tumor with uncertain histology. The gene discussed is PIK3CA; the disease is neoplasm.